<SEC-DOCUMENT>0001104659-23-067590.txt : 20230602
<SEC-HEADER>0001104659-23-067590.hdr.sgml : 20230602
<ACCEPTANCE-DATETIME>20230602163041
ACCESSION NUMBER:		0001104659-23-067590
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230602
DATE AS OF CHANGE:		20230602

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Annovis Bio, Inc.
		CENTRAL INDEX KEY:			0001477845
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				262540421
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39202
		FILM NUMBER:		23989320

	BUSINESS ADDRESS:	
		STREET 1:		1055 WESTLAKES DRIVE, SUITE 300
		CITY:			BERWYN
		STATE:			PA
		ZIP:			19312
		BUSINESS PHONE:		610-727-3913

	MAIL ADDRESS:	
		STREET 1:		1055 WESTLAKES DRIVE, SUITE 300
		CITY:			BERWYN
		STATE:			PA
		ZIP:			19312

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QR Pharma, Inc.
		DATE OF NAME CHANGE:	20091202
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>tm2317698d1_defa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SCHEDULE 14A</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Proxy Statement Pursuant to Section&nbsp;14(a)&nbsp;of
the<BR>
Securities Exchange Act of 1934</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Filed by the Registrant <FONT STYLE="font-family: Wingdings">&#120;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Filed by a Party other than the
Registrant <FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD><TD STYLE="text-align: justify">Preliminary Proxy Statement</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Confidential, for Use of the Commission Only (as permitted by
Rule&nbsp;14a-6(e)(2))</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD><TD STYLE="text-align: justify">Definitive Proxy Statement</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#120;</FONT></TD><TD STYLE="text-align: justify">Definitive Additional Materials</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD><TD STYLE="text-align: justify">Soliciting Material Pursuant to Section&nbsp;240.14a-12</TD>
</TR></TABLE>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="border-bottom: Black 1pt solid; font: 14pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Annovis Bio,&nbsp;Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Registrant as Specified In Its Charter)</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Person(s)&nbsp;Filing Proxy Statement, if other than the Registrant)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Payment of Filing Fee (Check the appropriate box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#120;</FONT></TD><TD STYLE="text-align: justify">No fee required.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Fee paid previously with preliminary materials.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD><TD STYLE="text-align: justify">Fee computed on table in exhibit required by Item 25(b)&nbsp;per
Exchange Act Rules&nbsp;14a6(i)(1)&nbsp;and 0-11</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2317698d1_defa14aimg01.jpg" ALT="" STYLE="width: 201px; height: 94px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Annovis Bio,&nbsp;Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>1055 Westlakes Drive, Suite&nbsp;300<BR>
Berwyn, PA 19312</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SUPPLEMENT DATED JUNE
2, 2023 TO THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>NOTICE OF ANNUAL MEETING
OF STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>AND</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PROXY STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FOR THE 2023 ANNUAL MEETING OF STOCKHOLDERS</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>To Be Held June&nbsp;15, 2023</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This supplement to the proxy statement (this &ldquo;Supplement&rdquo;)
for the 2023 Annual Meeting of Stockholders (the &ldquo;Annual Meeting&rdquo;) of Annovis Bio,&nbsp;Inc. (the &ldquo;Company&rdquo;) is
dated June&nbsp;2, 2023, and supplements the Notice of Annual Meeting of Stockholders and Proxy Statement (the &ldquo;Proxy Statement&rdquo;)
of the Company filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) and made available to stockholders on April&nbsp;28,
2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Supplement is being filed with the SEC and
being made available to stockholders on June&nbsp;2, 2023. The information in this Supplement is in addition to the information provided
by the Proxy Statement and, except for the changes referenced herein, this Supplement does not modify any other information set forth
in the Proxy Statement. <B>THE PROXY STATEMENT CONTAINS IMPORTANT ADDITIONAL INFORMATION AND THIS SUPPLEMENT SHOULD BE READ IN CONJUNCTION
WITH THE PROXY STATEMENT.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Removal of Proposal 3 from Stockholder Consideration</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On May&nbsp;30, 2023, the Company filed a Current
Report on Form&nbsp;8-K announcing that the Audit Committee (the &ldquo;Audit Committee&rdquo;) of the Board of Directors of the Company
(the &ldquo;Board&rdquo;) had approved the dismissal of WithumSmith+Brown, PC (&ldquo;Withum&rdquo;) as the Company&rsquo;s independent
registered public accounting firm, effective May&nbsp;25, 2023, and approved the engagement of Ernst&nbsp;&amp; Young LLP (&ldquo;EY&rdquo;)
as the Company&rsquo;s independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As a result of the change of independent registered
public accounting firm, the Company has determined to withdraw Proposal 3 from the agenda for the Annual Meeting. Proposal 3 called for
a vote on the ratification of the selection of Withum as the Company&rsquo;s independent registered public accounting firm for the fiscal
year ending December&nbsp;31, 2023. The Company does not intend to submit at the Annual Meeting any other proposal for ratification of
the appointment of its independent registered public accounting firm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As a result of the removal of Proposal 3, the Company
notes the following matters regarding voting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD>proxy cards or voting instructions previously received and providing directions for the voting on Proposal 1 (Election of Directors)
will remain valid and in effect, and will be voted as directed;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD>proxy cards or voting instructions previously received and providing directions for the voting on Proposal 2 (Approval of the Amendment
to the Company's Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 35,000,000
to 70,000,000 shares) will remain valid and in effect, and will be voted as directed</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD>proxy cards or voting instructions previously received and providing directions for the voting on Proposal 3 will not be voted on
Proposal 3;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD>the Company will not make available or distribute, and you do not need to sign, new proxy cards or submit new voting instructions
solely as a result of the removal of Proposal 3; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD>if you already submitted a proxy card or voting instructions through the internet at <I>http://www.viewproxy.com/AnnovisBio/2023 </I>or
by telephone at &nbsp;877-777-2857, you do not need to resubmit a proxy card or voting instructions with different directions, unless
you wish to change the votes you previously cast on Proposals 1 or 2.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Supplemental Disclosure for the Proxy Statement</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company is providing the following information
to stockholders as supplemental disclosure to the Proxy Statement, which has been reported by the Company in a Current Report on Form&nbsp;8-K
that was filed with the SEC on May&nbsp;30, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On May&nbsp;25, 2023, the Audit Committee dismissed
Withum as the Company&rsquo;s independent registered public accounting firm and approved the engagement of EY as the Company&rsquo;s independent
registered public accounting firm for the fiscal year ending December&nbsp;31, 2023. As a result of the engagement of EY, the Company
no longer expects that representatives of Withum will attend the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Withum&rsquo;s audit reports on the Company&rsquo;s
financial statements as of and for the years ended December&nbsp;31, 2022 and 2021 did not contain an adverse opinion or a disclaimer
of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles, except for Withum&rsquo;s report
for the year ended December&nbsp;31, 2022, which contained an explanatory paragraph regarding the substantial doubt about the Company&rsquo;s
ability to continue as a&nbsp;going&nbsp;concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">During the fiscal years ended December&nbsp;31,
2022 and 2021 and the subsequent interim period through May&nbsp;25, 2023: (1)&nbsp;there were no &ldquo;disagreements&rdquo; (as defined
in Item 304(a)(1)(iv)&nbsp;of Regulation S-K) with Withum on any matter of accounting principles or practices, financial statement disclosure,
or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Withum, would have caused Withum to make reference
to the subject matter of such disagreements in connection with its reports on the financial statements for such periods and (2)&nbsp;there
were no &ldquo;reportable events&rdquo; (as defined in Item 304(a)(1)(v)&nbsp;of Regulation S-K), except for the disclosure of the following
material weakness in the Company&rsquo;s internal control over financial reporting as disclosed in Part&nbsp;II,&nbsp;Item 9A of the Company&rsquo;s
Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2022: The Company did not design effective controls and procedures
related to the proper classification of research and development expenses, which impacted the Company&rsquo;s previously issued condensed
financial statements as of and for the three months ended March&nbsp;31, 2022, three and six months ended June&nbsp;30, 2022 and three
and nine months ended September&nbsp;30, 2022. Such material weakness resulted in a restatement of previously issued condensed financial
statements as of and for the three months ended March&nbsp;31, 2022, three and six months ended June&nbsp;30, 2022 and three and nine
months ended September&nbsp;30, 2022. This reportable event was discussed among the Company&rsquo;s management, the Audit Committee and
Withum. Withum has been authorized by the Company to respond fully to the inquiries of EY, the successor accountant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ADDITIONAL INFORMATION AND WHERE TO FIND IT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the Annual Meeting, the Company
previously filed its Proxy Statement with the SEC and made available the Proxy Statement, proxy card and documents incorporated by reference
to the Company&rsquo;s stockholders on April&nbsp;28, 2023. Before making any voting decision, you are urged to read the Proxy Statement,
including the documents incorporated by reference, and all related proxy materials carefully. Copies of the Proxy Statement, the documents
incorporated by reference and all other proxy materials are available at <I>http://www.viewproxy.com/AnnovisBio/2023</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company files annual, quarterly and current
reports, proxy statements and other information with the SEC. You can read these SEC filings free of charge at the SEC&rsquo;s website
at <I>www.sec.gov</I>. You may also access the Proxy Statement and Annual Report on Form&nbsp;10-K at <I>www.annovisbio.com</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2317698d1_defa14aimg01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2317698d1_defa14aimg01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !X .L# 2(  A$! Q$!_\0
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M"A,8P1_>-;5OXNU _!\>+)(X&OQIQNR@4B,L 3C&<XX]:#:-:4:<J<?M6O\
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MVR*](^-.C>)O$?ABUT;P[IK7:S3^9=,)43:J?=7YF&<L<\?W*W/AEX6D\'^
M]/TRX0)>L#/= $'$C\D9'!P,+G_9H Z^OF+XF02_#[XV6GB.U0^3<2)?!0,
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M'Z'WJ+M'V%? 8+-8>VI.TNZ_5?T_-GU%17S_ *3XY\0:.GEPWS2Q9SY=P/,
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7I^1TM%%%,\T**** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
